The purpose of this study is to develop and assess the efficacy of an integrated strategy that includes feasible and scalable...
This study is currently on hold. The study is designed to characterize the pharmacokinetics of DLM using a model-based...
This study is being done in people who are starting HIV treatment and who live in areas where the TB infection rate is high. The...
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
A5314 is a phase II randomized, double-blind, placebo-controlled 36-week trial that will examine the safety and efficacy of...
